Big news for stroke prevention: the Food and Drug Administration approved Sunharbo, a brand-new blood thinner from Bayer.
Unlike older medications, Sunharbo targets a different clotting protein (Factor XIa) to help stop strokes from happening again.
This approval comes after positive results from a global Phase 3 study and could make a real difference for hundreds of thousands of Americans each year.
Sunharbo taken once daily with antiplatelets
Sunharbo is taken once daily along with antiplatelet therapy and is the first Factor XIa inhibitor approved anywhere in the world.
By blocking harmful clot formation, it helps lower the risk of second strokes, something Dr. Ashkan Shoamanesh says is really important for people recovering from an initial stroke.
This new option could mean better outcomes and more hope for patients moving forward.